Pfizer’s Vydura recommended by NICE for acute migraines
The treatment is the first oral GPCR receptor antagonist class recommended for NHS use
Read More
Author: Jen Brogan
FDA approves Pfizer/BioNTech and Moderna’s adapted COVID-19 vaccines
The updated vaccines more closely target current circulating variants
Read More
MIT’s new technique to remotely evaluate cerebral palsy patients
The method could also be beneficial for Parkinson’s disease and strokes
Read More
Astellas to invest over €330m in a new facility in Ireland
The site will contribute to the development and commercialisation of antibody drugs
Read More
UK government invests £200m to boost NHS resilience this winter
The funding will reduce waiting lists and ease the demand on the NHS during Winter
Read More- NICE backs daratumumab quadruplet for newly diagnosed transplant‑ineligible myeloma
- Anocca doses first patients with precision TCR‑T therapy
- Connecta launches phase 2a trial of neuroplasticity modulator
- Aquipta recommended by NICE for acute migraine treatment
- Talvey accepted for use in Scotland for relapsed and refractory multiple myeloma
